Higher IGFBP-1 levels were statistically significantly associated with lower epicardial and intrathoracic adipose tissue, particularly in offspring of parents with exceptional longevity, suggesting circulating IGFBP-1 may be a novel biomarker for visceral adiposity and cardiometabolic risk stratification.
Key Findings
Results
Higher serum IGFBP-1 levels were statistically significantly associated with lower epicardial adipose tissue (EAT) and intrathoracic adipose tissue (IAT) in the overall study sample.
Study included n=102 participants from the LonGenity parent study at the Albert Einstein Institute of Aging, Bronx NY
Participants were Ashkenazi Jewish offspring of parents with exceptional longevity (OPEL) or usual survival (OPUS)
EAT and IAT were measured via non-contrast electrocardiogram-gated computed tomography (CT) for fat volume quantification
Multiple linear regression models were adjusted for demographic, clinical, and laboratory factors including age, BMI, HDL cholesterol, and cardiometabolic factors
Results
The inverse association between IGFBP-1 and both EAT and IAT was particularly significant among offspring of parents with exceptional longevity (OPEL).
In OPEL participants, the inverse relationship between IGFBP-1 and EAT/IAT remained statistically significant after full adjustment
Among OPUS participants, point estimates for the associations were directionally similar (inverse) but did not reach statistical significance
This suggests a potential differential effect of IGFBP-1 on adiposity based on parental longevity status
Results
The inverse association of IGFBP-1 with EAT and IAT remained significant after adjusting for multiple confounders.
Adjustment variables included age, body mass index, high-density lipoprotein cholesterol, and cardiometabolic factors
Cross-sectional study design was used for these analyses
The association persisted despite comprehensive covariate adjustment, suggesting an independent relationship
Background
The study investigated a population specifically enriched for healthy aging genetics through the LonGenity study design.
The LonGenity study was designed to investigate healthy aging in Ashkenazi Jewish individuals
Two groups were compared: OPEL (offspring of parents with exceptional longevity) vs. OPUS (offspring of parents with usual survival)
The study was conducted at the Albert Einstein Institute of Aging, Bronx NY
Higher serum IGFBP-1 is known to be associated with insulin sensitivity and reduced risk of obesity, diabetes, and atherosclerosis
Conclusions
IGFBP-1 is proposed as a novel biomarker for visceral adiposity and cardiometabolic risk stratification in older adults.
Epicardial and intrathoracic adipose tissue are established markers associated with increased atherosclerosis
The study was cross-sectional, and authors call for future studies to explore IGFBP-1's role in cardiovascular aging
Prior to this study, whether there was an inverse association of IGFBP-1 with EAT and IAT was unknown
Kankaria R, Charla J, Ye K, Slipczuk L, Dey D, Levsky J, et al.. (2026). Inverse association of insulin-like growth factor binding protein 1 with epicardial and intrathoracic adiposity in older adults: The Longenity study.. Diabetes research and clinical practice. https://doi.org/10.1016/j.diabres.2026.113099